BEUC phản đối Facebook thay đổi điều khoản dịch vụ của WhatsApp

Tổ chức Người tiêu dùng châu Âu (BEUC) ngày 12/7 thông báo rằng họ đã nộp đơn khiếu nại lên Ủy ban châu Âu (EC) nhằm chống lại nỗ lực của Facebook trong việc sửa đổi các điều khoản dịch vụ cho ứng dụng nhắn tin WhatsApp.

VDjhu6rGrzzhuq/hu7Lhu4Phu4Phu5jFqOG6v+G7hDnhu4Xhuq99xahVw7nGsEbhu6XGr+G6vzhA4bq3xq974bqrOcav4buz4buyPH0p4bqz4bqzxIPGr+G7hTjhu7LDs8ave2Q5xq97OTJmxq/EgzjhurNA4bq3xq8+w6A8OMavbWnGrzzDreG7ssavTjjhu7Lhu4Xhu4Phu5Hhur/hur9ULzjhu6pVVOG6v8avPOG6r+G7suG7g+G7g+G7mMWo4bq/4bu3feG7sj7FqFXhu4Rkxq88OOG7iTzGr+G6tjfhu4vhurk5xq/hu4U5MGbGrz5o4bq3N8avPDg6ZsavcWbGr1LDucawRuG7pVPGr+G6tzfhu7bDs8av4buq4buwL1jGr+G7hTjhuqnhurc3xq8p4bu04bqzxq/hu4cl4bq3N8avOOG6pcaveyPGr+G6t2Phur/Gr3tl4bq3xq/Egzg5MWbGr+G6t+G7uDnGr+G6rzDhurfGr8ONw7PGrynhu7LhurfGrzw4OmbGr3Fmxq9SxrDhu6VTxq/hurc4JeG6scavPDjhuqvhurc3xq/huq/hu7g5xq/hurfEkcav4bqvajzGrzzDreG7ssav4buz4buyPH0p4bqz4bqzxIPGr+G7heG7h+G6s+G6tzfGr205MzzGr+G7g2vhu7LGr3tkOcavPOG7tDzGr3s5MmbGr8SDOOG6s0DhurfGrz7DoDw4xq9tacavPDjhurPGr+G7ieG6tzfGrz5p4bq3N8av4bq3OCThurfGr+G7hTnhurfGr0444buy4buF4buD4buR4bq/4bq/UFQv4bq/VVThur/Grzzhuq/hu7Lhu4Phu4Phu5jFqOG6v8O54bqzPsOzxahVVDnhurE3xq884bqv4buy4buD4buD4buYxag84bqx4buDLeG6vzjhurPhu4XhurPFqMav4buFOeG7heG6r33hu5jFqMO5xrBG4bulxq/hur84QOG6t8ave+G6qznGr+G7s+G7sjx9KeG6s+G6s8SDxq/hu4U44buyw7PGr3tkOcavezkyZsavxIM44bqzQOG6t8avPsOgPDjGr21pxq88w63hu7LGr0444buy4buF4buD4buR4bq/4bq/xq84w6Hhurc4xq9A4bq3OMav4buqxajGr+G7g+G7hzzhu5jFqC8vPFAp4buy4bqz4buFOOG7suG6tzg44bqz4buyUG3hurcvOeG6sTcvPn3hu4PEg+G7heG6s+G6vy/hurd9buG7gy/hu7Dhu6rhu7BZL+G7qlhYPuG7sOG7qFnhu6jhu67hu6rhu7Dhu4Xhu6rhu6pY4bqv4buqUG59KeG6v8Woxq/hu7Lhuq/hu4Xhu5jFqMO5xrBG4bulxq/hur84QOG6t8ave+G6qznGr+G7s+G7sjx9KeG6s+G6s8SDxq/hu4U44buyw7PGr3tkOcavezkyZsavxIM44bqzQOG6t8avPsOgPDjGr21pxq88w63hu7LGr0444buy4buF4buD4buR4bq/4bq/xajGrz7hu7Lhu4Xhu7It4bq/OOG6s+G7heG6sy3hurPhu4c5Nznhurfhu7Lhuq8t4buD4buHPOG7mMWoOOG7heG7heG6v+G7g+G7oi8vPD7hurc54bqxN1BtOX3hu4Xhurfhu7LhurHhur/huq9m4buDUG3hurcv4buFV+G7sOG7qC9m4bq/4bqv4bqz4buyPn0+Lzl6PuG7g+G7gy/hu7Dhu6jhu7Dhu6pf4buoWF/hu6rhu7AvbeG6t+G7sl/hur/hurPhu4Xhu7Lhuq9f4buq4buoX+G7g2ZfxIM5feG6t1/hu4U4fV83OeG6szlf4bq34bqzOV8p4buy4buFX+G6t+G7suG6sV/hu7Dhu6jhu7Dhu6hfPuG6s1/hu4Xhu4VvbeG6t18pOeG6tzhfPDjhurPhurdfX+G7g2ZfxIM5feG6t1/DnV/hurc4OX1mX+G7gWbhurM8Xzc54buyX+G7hTnhurFfPOG7sjw4X+G7gWbhu7Lhurdf4bqvw7NfPDjhu7Lhu4VfPOG7sjxfPOG6s+G6tzdf4buFw7NfPOG6s+G6tzdf4bq3Nzh9X+G6r+G6s+G6t19W4buw4buo4buq4buuWeG7qFDDo+G6vzfFqMavL1XDuTk0Zsav4buF4buL4bq74bq3N8av4buJ4bq3N8avPmnhurc3xq/hu4U54bq3xq/hurc4JOG6t8avTjjhu7Lhu4Xhu4Phu5Hhur/hur/GrzzDreG7ssav4buz4buyPH0p4bqz4bqzxINQxq9S4buX4bq3OOG7osav4buR4buz4bq+L+G7hOG7hE9N4bq2U1Qv4bq/VVThur/Grzzhuq/hu7Lhu4Phu4Phu5jFqOG6v8O54bqzPsOzxahV4oCc4bu1I8avxIM4ZOG6tzfGr+G6r2LGrzzhuqnhurc3xq/hurc3ODPigJ3GrzzDreG7ssav4bqww7TGr3vhu7Lhurc3xq/hu4XDoeG6scavPOG7tDw4xq/Egzhmw7Mx4bq3xq/EgzhhPDjGr+G6tzfhu4vhurk5xq8+aOG6tzfGr+G6tzLhurfGr+G7hUDhurc3xq/hurc4JOG6t8av4buFOeG6t8avPMOt4buyxq844bqlxq88ODvhur/Gr+G6tzgu4bq3xq884bu0PMavezkyZsavxIM44bqzQOG6t8avPsOgPDjGr21pxq/hurHDqTnhu6DGr+G6tzjhu4vhurc3xq/hu7Phu7I8fSnhurPhurPEg8av4bq/OMOtxq/hurc4LuG6t8av4buHJeG6tzfGr205MzzGr+G6t+G7tsOzxq/hu4Mgxq88OOG6s8av4bq/OFvhur/Gr0444buy4buF4buD4buR4bq/4bq/xq88ODnhu7LGr+G7gyLGr+G6tzg5MmbGrz5sxq/huq85M2bGrzzDreG7ssav4bq3N+G7i+G6uTnGrz5o4bq3N8avOGXhurfGr23DqTnGr+G6seG7uOG6tzfGr28jxq84YznGrzw4YeG6tzjGr+G6r+G7tsav4buz4buyPH0p4bqz4bqzxINQVC/hur9VVOG6v8avPOG6r+G7suG7g+G7g+G7mMWo4bq/w7nhurM+w7PFqFXhu6Xhu7Q8xq/hurc44bu2xq/hu4FmQOG6t8av4bqvw7LGr23hu7bGrzzhu7Q8xq/hurc44bu2xq844bqz4bu44buFxq97Y+G6tzfGr20yxq/hu4Fmw7My4bq3xq/hu4c5MOG6tzfGr+G7heG7i8aveyPGr+G6rzDhurfGr+G7tOG6t8ave2Phurc3xq/hu4U44bu0Ocav4bq34bu2w7PGr23hu7bGrzw4YeG6tzjGr+G6vzjDrcav4bqxY+G7hcav4buD4bqrxq/hu4Fm4bqrPMavNznhu7LGry3Grynhu7LhurPGrzdi4bqxxq88QMav4buFOOG7tuG6tzjGr205MOG6t8avxrBGxq/huq/hu7bGr8Wp4buJPMavLcaveyPGr23hu7bhurPGrzxmYzzGr3s0xq/hu7Thur/Gr3sq4buFxq884bu0PMav4bqvM+G6tzjGrzw74bqxxq/hu4Xhu7jhurHGr+G7hTjhurk5xq974bqrOcavbcOpOcav4buz4buyPH0p4bqz4bqzxINQVC/hur9VVOG6v8avPOG6r+G7suG7g+G7g+G7mMWo4bq/w7nhurM+w7PFqFXhu4Thu4fhurPhurc3xq/hurFj4buFxq/hu4U44bqp4bq3N8avKeG7tOG6s8avbTLGr3tl4bq3xq/Egzg5MWbGr+G6t+G7uDnGrzzDreG7ssav4bqxw6Hhurc44bugxq/DucawRuG7pcavPOG7tOG6s8avKWZjPMav4buz4buyPH0p4bqz4bqzxIPGr3sjxq/igJzEgzjhuqnhurc3xq884bqp4bq3N8avKSXhurc34oCdxq/Egzg5xq83OsOzxq/hu7Thur/Gr+G6r2o8xq8pZmM8xq/hurc34buL4bq5OcavPmjhurc3xq/hur84QDnGrzw4O+G6v8av4bq3OC7hurfGrynhu7bhurfGrzc54buy4bqzxq884bu0PMavPmzGr+G6rzkzZsav4bqx4bu2xq/Egzjhuqnhurc3xq83OUA5xq/hu4U4YTw4xq9tMsavbTkzPMav4bq34bu2w7NQVC/hur9VVOG6v8avPOG6r+G7suG7g+G7g+G7mMWo4bq/w7nhurM+w7PFqFXhu4Rk4bq3N8avNznhu7ThurHGr3vhuqs8xq/DucawRuG7pcav4bqw4bqz4bq3OeG7gWZ9xq/hu7XhurPDs33hurfhu4PGrzw44bqzxq8pOTHhu4Xhu6DGr0444buy4buF4buD4buR4bq/4bq/xq97I8avw7MwZsavPCxmxq/hurc34buL4bq5OcavPmjhurc3xq/hur84QDnGr3ti4bq3N8avw7LGr23DqTnGrzw4YeG6tzjGr+G7g+G7tDw4xq/hurHDqTnGrzzDreG7ssavOOG6pcavezTGrzzhurXGr+G7hTg0xq/hu4U5MeG6v8av4buFaTzGr+G7g2vGrz5p4bq3N8avPsOgPDjGr21pxq/hu4Phu7Jmxq/hurc34bu2w7PGr+G7qlYvVlDGr+G7hDh94bqzxq974bq14bugxq8pQOG6t8avPC7hur/Gr+G6tzgu4buFxq88w63hu7LGr+G7ieG6tzfGrz5p4bq3N8av4bq34bu2w7PGr+G7gyDGrzw44bqzxq/hur84W+G6v8avPDg54buyxq/hu4Mixq/hu4U4MOG6scav4buFOOG6qeG6tzfGr+G7hTnhurfGr+G7hcSpxq9OOOG7suG7heG7g+G7keG6v+G6v8avbcOpOcav4buz4buyPH0p4bqz4bqzxIPGr23hu7bGrzzhu7Q8xq/hu4nhurc3xq8+aeG6tzfGr8SDOOG7tDzGr+G6tzjhu4vGr+G7ueG6t+G7g+G7heG7sjfhu4fhu7LhurHGr23hu7bGr+G6sH3hu4Phu4N94bq3N33hu4dQVC/hur9VVOG6v8avPOG6r+G7suG7g+G7g+G7mMWo4bq/w7nhurM+w7PFqFXGsOG7pcav4buF4buH4bqz4bq3N8av4bq3OGzhurc3xq/hurc94bqxxq83LOG6t8avezrDs8aveyPGr+G7hTkx4bq3xq844bu24bq3OMav4bqxY+G7hcav4bqv4bqz4bu44buFxq88ZmM8xq97OTJmxq/hu4Xhu4fhu7LGr23hu7bGrzjhu7bhurc4xq97Y+G6tzfGr+G6tzgl4bqxxq9t4bu24bqzxq/hurc4bOG6tzfGr+KAnDcjxq/Egzhk4bq3N8av4bqvYuKAncavPOG6qeG6tzfGr+G6tzc4M8av4bqww7TGr+G6seG7tsavOOG6pcavPOG6sznGr+G6r+G7tsav4bq3OGzhurc3xq/igJzhurc34buL4bq5OcavN+G7tDzGrzxk4bq3N8av4bu54bq34buFfeG7h+G6t33hu4VQ4oCdUC9QVC/hur9VVOG6v8avPOG6r+G7suG7g+G7g+G7mMWo4bq/4buRZuG7hTjhurPhu4fFqFVS4buE4buET03hurYvTTl94buF4bq34buy4bqxK1NUL+G6v1U=

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh